| Nerve–cancer cell cross-talk: a novel promoter of tumor progression P Jobling, J Pundavela, SMR Oliveira, S Roselli, MM Walker, ... Cancer research 75 (9), 1777-1781, 2015 | 233 | 2015 |
| Nerve fibers infiltrate the tumor microenvironment and are associated with nerve growth factor production and lymph node invasion in breast cancer J Pundavela, S Roselli, S Faulkner, J Attia, RJ Scott, RF Thorne, ... Molecular oncology 9 (8), 1626-1635, 2015 | 131 | 2015 |
| NGF and ProNGF: Regulation of neuronal and neoplastic responses through receptor signaling RA Bradshaw, J Pundavela, J Biarc, RJ Chalkley, AL Burlingame, ... Advances in biological regulation 58, 16-27, 2015 | 125 | 2015 |
| ProNGF correlates with Gleason score and is a potential driver of nerve infiltration in prostate cancer J Pundavela, Y Demont, P Jobling, LF Lincz, S Roselli, RF Thorne, ... The American journal of pathology 184 (12), 3156-3162, 2014 | 108 | 2014 |
| SOD1 protein aggregates stimulate macropinocytosis in neurons to facilitate their propagation R Zeineddine, JF Pundavela, L Corcoran, EM Stewart, D Do-Ha, M Bax, ... Molecular neurodegeneration 10, 1-18, 2015 | 85 | 2015 |
| Sortilin is associated with breast cancer aggressiveness and contributes to tumor cell adhesion and invasion S Roselli, J Pundavela, Y Demont, S Faulkner, S Keene, J Attia, CC Jiang, ... Oncotarget 6 (12), 10473, 2015 | 81 | 2015 |
| FAT1 cadherin acts upstream of Hippo signalling through TAZ to regulate neuronal differentiation AF Ahmed, CE de Bock, LF Lincz, J Pundavela, I Zouikr, E Sontag, ... Cellular and molecular life sciences 72, 4653-4669, 2015 | 47 | 2015 |
| After Nf1 loss in Schwann cells, inflammation drives neurofibroma formation JS Fletcher, J Pundavela, N Ratner Neuro-oncology advances 2 (Supplement_1), i23-i32, 2020 | 29 | 2020 |
| Cxcr3-expressing leukocytes are necessary for neurofibroma formation in mice JS Fletcher, J Wu, WJ Jessen, J Pundavela, JA Miller, E Dombi, MO Kim, ... JCI insight 4 (3), 2019 | 29 | 2019 |
| ProNGF is a potential diagnostic biomarker for thyroid cancer S Faulkner, S Roselli, Y Demont, J Pundavela, G Choquet, P Leissner, ... Oncotarget 7 (19), 28488, 2016 | 29 | 2016 |
| Nuclear magnetic resonance spectroscopy of human body fluids and in vivo magnetic resonance spectroscopy: potential role in the diagnosis and management of prostate cancer N Gholizadeh, J Pundavela, R Nagarajan, A Dona, S Quadrelli, T Biswas, ... Urologic Oncology: Seminars and Original Investigations 38 (4), 150-173, 2020 | 21 | 2020 |
| WNT5A inhibition alters the malignant peripheral nerve sheath tumor microenvironment and enhances tumor growth CS Thomson, J Pundavela, MR Perrino, RA Coover, K Choi, KE Chaney, ... Oncogene 40 (24), 4229-4241, 2021 | 7 | 2021 |
| Neurotrophin synthesis by mammary cells during lactation (623.19) F Hassiotou, AJ Twigger, J Pundavela, S Roselli, P Hartmann, D Geddes, ... The FASEB Journal 28, 623.19, 2014 | 3 | 2014 |
| C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosis MR Perrino, N Ahmari, A Hall, M Jackson, Y Na, J Pundavela, S Szabo, ... Life science alliance 7 (5), 2024 | 1 | 2024 |
| Use of RAS isoforms in nerve tumors N Ratner, L Hu, J Pundavela, JA Epstein MOLECULAR CANCER RESEARCH 21 (5), 2023 | | 2023 |
| Abstract IA17: Use of RAS isoforms in nerve tumors N Ratner, L Hu, J Pundavela, JA Epstein Molecular Cancer Research 21 (5_Supplement), IA17-IA17, 2023 | | 2023 |
| Secretome analysis of human schwann cells derived from malignant peripheral nerve sheath tumor A Ferdoushi, MFB Jamaluddin, X Li, J Pundavela, S Faulkner, ... Proteomics 22 (1-2), 2100063, 2022 | | 2022 |
| Neuro-Oncology Advances KE Blethen, TA Arsiwala, RA Fladeland, SA Sprowls, DM Panchal, ... | | 2021 |
| Development of chimeric forms of IFN-alpha for" on demand" in vivo cancer gene therapy. JS Fletcher, J Wu, WJ Jessen, J Pundavela, E Dombi, MO Kim, TA Rizvi, ... CANCER IMMUNOLOGY RESEARCH 8 (4), 97-98, 2020 | | 2020 |
| Abstract B32: Cxcr3-expressing leukocytes are necessary for neurofibroma formation in mice JS Fletcher, J Wu, WJ Jessen, J Pundavela, E Dombi, MO Kim, TA Rizvi, ... Cancer Immunology Research 8 (4_Supplement), B32-B32, 2020 | | 2020 |
Phillip JoblingUniversity of Newcastle, AustraliaEmail confirmado em newcastle.edu.au
